Date published: 2026-5-30

1-800-457-3801

SCBT Portrait Logo
Seach Input

RES4-22 Inhibitors

RES4-22 inhibitors belong to a class of chemical compounds that are designed to interact with specific biological molecules. The designation "RES4-22" likely refers to a particular target or a key characteristic of the molecule's structure or function, which is a common convention in biochemical nomenclature. These inhibitors function by binding to their target with high affinity, thereby altering its activity. The target could be an enzyme, a receptor, or any other protein that plays a critical role in a biochemical pathway. The inhibition process usually involves the compound mimicking the natural substrate or ligand of the protein, fitting into its active site or ligand-binding domain and preventing the normal interaction that would occur with the physiological substrates or ligands.

The development of RES4-22 inhibitors would typically be the result of extensive research into the structure-activity relationships (SAR) governing the interaction between the inhibitor and its target. This entails a deep understanding of the molecular makeup of the target site and the way in which inhibitors can influence its function. Chemists would synthesize a variety of compounds with different substituents and functional groups to determine the molecular framework that results in the most effective inhibition. Advanced techniques like X-ray crystallography, nuclear magnetic resonance (NMR) spectroscopy, and computational modeling might be employed to elucidate the precise manner in which these inhibitors engage with their targets and to design more potent inhibitors. Stability, solubility, and specificity are key factors that are refined during the development of RES4-22 inhibitors to ensure that they effectively and selectively interact with their intended target without affecting other proteins or pathways.

SEE ALSO...

Items 11 to 12 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

U-0126

109511-58-2sc-222395
sc-222395A
1 mg
5 mg
$64.00
$246.00
136
(2)

U0126 is an inhibitor of MEK1/2, which are involved in the MAPK/ERK pathway. If RES4-22 is activated by ERK signaling, U0126 would inhibit RES4-22 by blocking the activation of MEK1/2 and subsequently ERK.

SL 0101-1

77307-50-7sc-204287
sc-204287A
sc-204287B
sc-204287C
sc-204287D
1 mg
10 mg
25 mg
50 mg
100 mg
$200.00
$353.00
$772.00
$1230.00
$2070.00
3
(1)

SL0101 is an inhibitor of ribosomal S6 kinase (RSK). If the activation of RES4-22 is RSK-dependent, SL0101 would lead to the inhibition of RES4-22 by inhibiting the kinase activity of RSK, which may phosphorylate substrates involved in RES4-22 activation.